WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
Maila's PhD thesis, which was jointly supervised by Mazenda and Professor Lianne Malan, focused on developing a new model for the South African housing sector. Q:What's the current system and what's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback